Afya Limited (NASDAQ:AFYA) Q3 2022 Earnings Call Transcript

Luis Andre Blanco: Thanks, Cepeda. I will start with that and Virgilio will make some additional points. Regarding UNIT, we are planning to increase that. We are, right now negotiating — in the final negotiation of this increase in that, to finance the down payment that we have for that we needs deal (ph). As we mentioned, we expect to close that in next year, but we didn’t close the financial date of it right now. We are very in advance but we haven’t close it until now and we expect to reach the final agreements in the beginning of December. Regarding Medcel, starts with , we’ve made completely — transformations, completely rejiggering regarding Medcel. We changed the product itself. We changed the price. We changed the way we adverse this product and we — and the way we package this product.

Starting with the product itself instead of having a very complete product to fit all kind of students, we kind of focus it for each one of the institutions that the students wants to pass. We exclude the physical book from the value propositions. We — right now, we offer the physical book as an add-on. So the basic package is an e-book of it. Instead of providing all the contents for the students in the first time, we made an assessment of these students and we impact these students with the content that most needed to get the minimum grades that is needed for the institution that he wants to pass for this specific subject. If this assessment — the first assessment, he is performing well, he will be impacted by a very short content and then go to the simulations, the test simulations, and if he is not very well positioned with his grade, so he’s going to beat that off the content that is needed to him to get improvement.

So we make these kind of changes in product. In terms of pricing, we have increased pricing. The pricing for the 2022 collections, it was around 4,500 per year — per one year, and we increased this pricing for about BRL7,000. So we increased the pricing for the product. Regarding the way that we sell the product, we give more protagonist before our teachers. We’re being more on the social networks instead of addings. But we’ve , we’ve three new contacts inside of our social networks. And last but not least, we are combo the products to offer what we say that the pillar one offer. Instead of just offering Medcel itself, now we are offering Medcel combining with mentoring and combining with some features that come from Cardio papers. So we are that and offering to our students, and these kind of offers are being very well received by these students.

But it’s a turnaround of all this offers that we put in place right now. Virgilio?

Virgilio Gibbon: Yeah, Mauricio. Just to add here, just to remember that we acquired Cardio papers and Alem da Medicina. In those acquisitions, we have many experts, physicians that went to entering on our pillar one helping us to review our products and our offer to the market. So there are influencers, there are experts in each area. So we — as Blanco said, we are giving much more, putting our professor, our teachers in front of the student in tailoring the content for each type of residents, for each type of product that they are going to top line. So we have much more experts tailoring the content that have us to change our price and also to revamp our product. So this is in the very beginning. So we have the Black Friday.

That’s a very strong process during November. And since we launched, we are seeing very good figures in terms of numbers, but it’s still in the beginning where we are going to March, April next year to have our final results from this new season.

Mauricio Cepeda: Great. So — and an additional complement to my question, so by remodeling the product, by re-engineering the product, do you expect this to change the way you sell and recognize revenues of it, should it be more continues now? How do you think about that?